Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
5.390
Zitationen
42
Autoren
2018
Jahr
Abstract
Für dieses Paper ist kein Abstract in der Datenbank hinterlegt.
Abstract beim Verlag einsehenÄhnliche Arbeiten
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
2016 · 3.695 Zit.
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 · 3.521 Zit.
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 · 3.453 Zit.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 · 3.364 Zit.
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
2016 · 3.246 Zit.
Autoren
- Sanjeev Mariathasan
- Shannon J. Turley
- Dorothee Nickles
- Alessandra Castiglioni
- Kobe Yuen
- Yulei Wang
- Edward E. Kadel
- Hartmut Koeppen
- Jillian L. Astarita
- Rafael Cubas
- Suchit Jhunjhunwala
- Romain Banchereau
- Yagai Yang
- Yinghui Guan
- Cécile Chalouni
- James Ziai
- Yasin Şenbabaoğlu
- Stephen P. Santoro
- Daniel Sheinson
- Jeffrey Hung
- Jennifer M. Giltnane
- Andrew A. Pierce
- Kathryn Mesh
- Steve Lianoglou
- Johannes Riegler
- Richard A.D. Carano
- Pontus Eriksson
- Mattias Höglund
- Loan Somarriba
- Daniel L. Halligan
- Michiel S. van der Heijden
- Yohann Loriot
- Jonathan E. Rosenberg
- Lawrence Fong
- Ira Mellman
- Daniel S. Chen
- Marjorie Green
- Christina Louise Derleth
- Gregg Fine
- Priti S. Hegde
- Richard Bourgon
- Thomas Powles
Institutionen
- Lund University(SE)
- Fios Genomics (United Kingdom)(GB)
- The Netherlands Cancer Institute(NL)
- Institut Gustave Roussy(FR)
- Université Paris-Sud(FR)
- Memorial Sloan Kettering Cancer Center(US)
- University of California, San Francisco(US)
- UCSF Helen Diller Family Comprehensive Cancer Center(US)
- Queen Mary University of London(GB)